Clinical Trials · NCT01154933

Exeantide in Type 2 Diabetes on Insulin

CompletedPhase 2Exenatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University at Buffalo
Enrollment
24
Start date
Apr 2008
Locations
1 site, United States
Primary endpoint
Fasting Insulin
View Exenatide compound reference